Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,568,731,308
+$65,949,506 QoQ
Shares Held
10,114,310
-1.2% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#33
of 4,664 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$304,764
PutShares
1,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RAYMOND JAMES FINANCIAL INC holds $10,536,270,733 across 17 Drug Manufacturers - General names. JNJ ranks #2 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
10,410,159 | $2,619,612,407 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
10,114,310 | $2,568,731,308 | |
| 3 | LLY |
ELI LILLY & Co
|
1,713,850 | $2,055,643,274 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,236,773 | $801,425,329 | |
| 5 | AMGN |
Amgen Inc
|
1,602,419 | $580,267,967 | |
| 6 | AZN |
Astrazeneca PLC
|
2,409,624 | $456,912,900 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,436,019 | $307,766,638 | |
| 8 | PFE |
Pfizer Inc
|
11,942,054 | $287,564,657 |
All Filings in JNJ
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,568,731,308 | 10,114,310 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $304,764 | 1,200 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $2,502,781,802 | 10,238,839 | Shares | Defined | 2026-05-14 | |
| 2026-03-31 | $268,884 | 1,100 | Put | Defined | 2026-05-14 | |
| 2025-12-31 | $2,143,775,389 | 10,358,905 | Shares | Defined | 2026-02-18 | |
| 2025-12-31 | $206,950 | 1,000 | Put | Defined | 2026-02-18 | |
| 2025-09-30 | $1,879,723,246 | 10,137,651 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,442,993,199 | 9,446,764 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,570,192,023 | 9,468,114 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,339,878,700 | 9,264,823 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||